Assyro AI

Orange Book product · Brand (NDA)

PATADAY ONCE DAILY RELIEF

OLOPATADINE HYDROCHLORIDE

Brand (NDA)NDA 206276OTC ALCON LABS INC

At a glance

Jan 30, 2015

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 30, 2015

    11 yr 7 mo ago

  2. Today

  3. Patent 8791154 expires

    Listed drug product patent expiration.

    May 19, 2032

    in 6 yr

  4. Patent 9533053 expires

    Listed drug product patent expiration.

    May 19, 2032

    in 6 yr

Pharmaceutical detail

Active ingredient

OLOPATADINE HYDROCHLORIDE

Strength

EQ 0.7% BASE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

Not listed

Application

NDA 206276

Product number

001

Marketing status

OTC

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8791154May 19, 2032in 6 yr
ProductU-1680
9533053May 19, 2032in 6 yr
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.